ARE LABS · PLATFORM · 2026

Aerosol Research and Engineering Labs

Elevating Innovation
One Aerosol at a Time.

Independent aerosol science for bioaerosol, pharmaceutical, inhalation, emissions, surface, and package integrity studies. Precision instrumentation meets regulatory rigor.

Scope a study Explore testing

PARTICLE VORTEX ONLINE

We test

Drug delivery devices, air cleaners, respirators, packaging, antimicrobial surfaces, and air-interacting products.

We measure

Particle size, aerosol dose, microbial reduction, emissions, package integrity, and inhalation performance.

We report

Protocols, controls, figures, datasets, and interpretation limits in a reviewable evidence package.

ARE Labs quality recordU.S. EPAFIFRA GLPInspection completed08 · 2026

Independent regulatory oversight

U.S. EPA FIFRA GLP inspected.

ARE Labs completed its first on-site U.S. EPA FIFRA GLP facility inspection and selected study audit under 40 CFR Part 160 in August 2026.

Review regulatory oversight

Proof scale

900+

Studies performed across aerosol, bioaerosol, and inhalation programs.

ARE Labs turns product claims, technical questions, and regulatory evidence needs into controlled laboratory studies and defensible reports.

EPA

FIFRA GLP inspected · Aug 2026

17+

Years in operation

17025

ISO/IEC accredited testing scope

BSL-2

Bioaerosol capable

Ready to scope

Bring us the aerosol question. Leave with a study plan.

Send the device, formulation, claim, or regulatory frame. ARE Labs will return a scoped method plan with the controls, deliverables, and timeline needed to move.

Request a quote Browse services

What ARE Labs does

Independent testing for products that move through air.

ARE Labs measures aerosol behavior, microbial challenge, inhalation performance, emissions, surface efficacy, and package integrity, then turns the results into clear reports.

Pharmaceutical aerosol

Dose, particle size, and inhalation performance translated into defensible data.

ARE Labs builds method plans around the formulation, device, flow path, and decision. Outputs can include particle size, emitted dose, delivered dose, comparability, and limits of interpretation.

Open evidence path

MDI / DPI / nebulizer / nasal sprayIllustrative data

Fig 2 · stage massesmass / stage

Throat9.1

S1 6.514

S2 4.423

S3 3.337

S4 2.029

S5 1.116

MOC7.4

010203040 µg

Stage cutS3peak

Illustrative stage masses · cut sizes in µm · not ARE study results

Bioaerosol and air-device claims

Challenge studies for air devices, filters, and antimicrobial claims.

For air treatment, antimicrobial, filtration, and room-device programs, ARE Labs controls organisms, aerosol generation, sampling, timing, recovery, and reporting so claims are tested against defined conditions.

Open evidence path

Room device / filter / disinfection / reductionIllustrative data

Fig 3 · bioaerosol decaycontrol vs device

S. aureusMS2 virussolid = device on · dashed = untreated control

Illustrative curves · CFU/m³ for bacteria, PFU/m³ for MS2 · not ARE study results

High-tech measurement stack

Measurement strategy selected around the question.

No single readout answers every aerosol question. ARE Labs combines particle physics, analytical chemistry, device handling, environmental controls, and standards mapping into a fit-for-purpose study.

Open evidence path

Illustrative size profileIllustrative data

Fig 1 · particle-size distributionaero. dia.

Illustrative particle-size curve · relative signal versus aerodynamic diameter · not ARE study results

Applications

Testing for products and operating environments.

Start from the product or facility when the evidence need is commercial, regulated, or claim-critical. These application paths lead to aerosol, bioaerosol, inhalation, surface, and package integrity methods.

View all applications Scope a study

NebulizersOutput rate, particle size, and delivered dose.MMAD / dose / output Intranasal drug deliverySpray pattern, plume geometry, and dose delivery.spray / plume / dose Air purifiersCADR, bioaerosol reduction, and emissions.CADR / challenge / VOC Surface antimicrobial testingCarrier studies, time-kill, and biofilm efficacy.carrier / residual / kill CPAP / BiPAP / PAPEmissions, VOC, and breathing-simulation studies.emissions / VOC / flow Sterile package integrityContainer closure integrity and aging context.CCI / aging / sterility

Browse all applications

Study flow

Custom study design, made visible.

Method choice, controls, standards alignment, and deliverables are defined around the decision the data has to support.

Define the decision

We identify the claim, change, exposure question, or submission need the data must support.

Select the method

Instruments, challenge conditions, flows, replicates, controls, and standards alignment are set before the run.

Run the study

Samples move through controlled aerosol, bioaerosol, analytical, or environmental workflows with records attached.

Report the evidence

Reports include methods, controls, figures, raw datasets, and clear limits of interpretation.

Choose your entry point

Three clear ways into the site.

Start with the job at hand: scope a study, browse the method catalog, or understand the standards logic behind the work.

I have a product or claim

Start with the decision that needs evidence.

Use this path when a device, formulation, surface, or package needs data before launch, submission, or change control.

Scope a study

I need a test method

Browse by study type and measured output.

Go straight to aerosol, bioaerosol, inhalation, gas/VOC, surface, package integrity, and stability capabilities.

Explore services

I need technical context

Map the standards, claims, and study logic.

Use the standards and research library when the problem is still being framed and the evidence path is not obvious.

Review standards